Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AC Immune SA
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
May 31, 2026
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
May 29, 2026
AC Immune First Quarter 2026 Financial and Corporate Updates
May 27, 2026
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer’s Disease
May 27, 2026
AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly
May 24, 2026
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
May 20, 2026
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026
May 16, 2026